Today, the National Forum’s Executive Director, John Clymer, provided comments during the CMS’ Medicare Drug Price Negotiation Program Patient-Focused Listening Session on Xarelto.
The National Forum’s position has a strong foundation in the Value & Access Collaborative’s goal and strategies, reflecting a consensus among organizations representing patients, providers, public health, payers, purchasers, and pharma.
